CN1680240A - 含白藜芦醇和大豆异黄酮的组合物及其制备方法与应用 - Google Patents
含白藜芦醇和大豆异黄酮的组合物及其制备方法与应用 Download PDFInfo
- Publication number
- CN1680240A CN1680240A CN 200410026030 CN200410026030A CN1680240A CN 1680240 A CN1680240 A CN 1680240A CN 200410026030 CN200410026030 CN 200410026030 CN 200410026030 A CN200410026030 A CN 200410026030A CN 1680240 A CN1680240 A CN 1680240A
- Authority
- CN
- China
- Prior art keywords
- resveratrol
- extract
- composition
- soybean
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 244000068988 Glycine max Species 0.000 title claims abstract description 69
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 69
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title claims abstract description 63
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 235000008696 isoflavones Nutrition 0.000 title claims abstract description 53
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 235000021283 resveratrol Nutrition 0.000 title claims abstract description 15
- 229940016667 resveratrol Drugs 0.000 title claims abstract description 15
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 18
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 9
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 110
- 239000000284 extract Substances 0.000 claims description 58
- 235000018991 trans-resveratrol Nutrition 0.000 claims description 48
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 40
- 230000037396 body weight Effects 0.000 claims description 29
- 230000000694 effects Effects 0.000 claims description 26
- 230000037182 bone density Effects 0.000 claims description 21
- 229940011871 estrogen Drugs 0.000 claims description 17
- 239000000262 estrogen Substances 0.000 claims description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 16
- 238000002425 crystallisation Methods 0.000 claims description 15
- 230000008025 crystallization Effects 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 235000009392 Vitis Nutrition 0.000 claims description 8
- 241000219095 Vitis Species 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000006166 lysate Substances 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 230000003712 anti-aging effect Effects 0.000 claims description 4
- -1 each 2 hours Chemical compound 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 3
- 239000004411 aluminium Substances 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000005502 peroxidation Methods 0.000 claims description 3
- 238000010898 silica gel chromatography Methods 0.000 claims description 3
- 239000001117 sulphuric acid Substances 0.000 claims description 3
- 235000011149 sulphuric acid Nutrition 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract 1
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract 1
- 240000006365 Vitis vinifera Species 0.000 abstract 1
- 235000014787 Vitis vinifera Nutrition 0.000 abstract 1
- 229940087559 grape seed Drugs 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 36
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 32
- 210000000689 upper leg Anatomy 0.000 description 21
- 238000012360 testing method Methods 0.000 description 19
- 229910000019 calcium carbonate Inorganic materials 0.000 description 16
- 239000011575 calcium Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 12
- 230000001076 estrogenic effect Effects 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 238000010632 SOD assay Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000010630 lipid peroxidation (MDA) assay Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 241000255601 Drosophila melanogaster Species 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 244000153955 Reynoutria sachalinensis Species 0.000 description 2
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005008 domestic process Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002745 epiphysis Anatomy 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
实验组 | 阴性组 | 阳性组 | |
体重(g) | 17.9±1.14 | 19.7±1.09 | 21.7±2.05 |
子宫百分重(%) | 0.059±0.005 | 0.046±0.005 | 0.100±0.021 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100260306A CN100441555C (zh) | 2004-04-09 | 2004-04-09 | 含白藜芦醇和大豆异黄酮的组合物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100260306A CN100441555C (zh) | 2004-04-09 | 2004-04-09 | 含白藜芦醇和大豆异黄酮的组合物及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1680240A true CN1680240A (zh) | 2005-10-12 |
CN100441555C CN100441555C (zh) | 2008-12-10 |
Family
ID=35067118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100260306A Expired - Lifetime CN100441555C (zh) | 2004-04-09 | 2004-04-09 | 含白藜芦醇和大豆异黄酮的组合物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100441555C (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008051586A3 (en) * | 2006-10-24 | 2008-09-25 | David W Krempin | Anti-resorptive and bone building dietary supplements and methods of use |
US8202556B2 (en) | 2009-08-13 | 2012-06-19 | Access Business Group International Llc | Topical composition with skin lightening effect |
CN103565827A (zh) * | 2013-11-07 | 2014-02-12 | 苏州冉新生物技术有限公司 | 含有白藜芦醇的片剂 |
CN103599096A (zh) * | 2013-11-06 | 2014-02-26 | 苏州冉新生物技术有限公司 | 白藜芦醇片 |
CN103598579A (zh) * | 2013-11-08 | 2014-02-26 | 苏州冉新生物技术有限公司 | 含有大豆异黄酮的保健食品 |
CN105030610A (zh) * | 2015-08-18 | 2015-11-11 | 广州栋方生物科技股份有限公司 | 一种抗衰老组合物及其制备方法 |
CN110484416A (zh) * | 2019-09-17 | 2019-11-22 | 陈夕成 | 一种女性更年期保健酒及其制备方法和应用 |
CN114984126A (zh) * | 2022-07-15 | 2022-09-02 | 深圳德荫堂生物科技有限公司 | 一种适用女性补充荷尔蒙的生物药剂及生产方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102895463B (zh) * | 2012-09-29 | 2013-12-25 | 马南行 | 一种外用调节内分泌组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1351985A (zh) * | 2000-11-13 | 2002-06-05 | 潘君琦 | 一种白藜芦醇的生产工艺及其在食品饮料葡萄酒中的运用 |
CN1176602C (zh) * | 2002-12-06 | 2004-11-24 | 上海现代中医药技术发展有限公司 | 一种增加骨密度和延缓衰老的保健食品及其制备方法 |
-
2004
- 2004-04-09 CN CNB2004100260306A patent/CN100441555C/zh not_active Expired - Lifetime
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266440B (zh) * | 2006-10-24 | 2015-06-17 | 戴维·W·克雷姆平 | 抗再吸收的和造骨的食物增补剂和使用方法 |
WO2008051594A3 (en) * | 2006-10-24 | 2008-10-09 | David W Krempin | Anti-resorptive and bone building dietary supplements and methods of use |
EP2415469A1 (en) * | 2006-10-24 | 2012-02-08 | David W. Krempin | Anti-Resorptive and Bone Building Dietary Supplements and Methods of Use |
WO2008051586A3 (en) * | 2006-10-24 | 2008-09-25 | David W Krempin | Anti-resorptive and bone building dietary supplements and methods of use |
US11207368B2 (en) | 2006-10-24 | 2021-12-28 | Murray Mary A | Anti-resorptive and bone building dietary supplements and methods of use |
US9446087B2 (en) | 2006-10-24 | 2016-09-20 | David W. Krempin | Anti-resorptive and bone building dietary supplements and methods of use |
US8202556B2 (en) | 2009-08-13 | 2012-06-19 | Access Business Group International Llc | Topical composition with skin lightening effect |
CN103599096A (zh) * | 2013-11-06 | 2014-02-26 | 苏州冉新生物技术有限公司 | 白藜芦醇片 |
CN103565827A (zh) * | 2013-11-07 | 2014-02-12 | 苏州冉新生物技术有限公司 | 含有白藜芦醇的片剂 |
CN103598579A (zh) * | 2013-11-08 | 2014-02-26 | 苏州冉新生物技术有限公司 | 含有大豆异黄酮的保健食品 |
CN105030610A (zh) * | 2015-08-18 | 2015-11-11 | 广州栋方生物科技股份有限公司 | 一种抗衰老组合物及其制备方法 |
CN110484416A (zh) * | 2019-09-17 | 2019-11-22 | 陈夕成 | 一种女性更年期保健酒及其制备方法和应用 |
CN114984126A (zh) * | 2022-07-15 | 2022-09-02 | 深圳德荫堂生物科技有限公司 | 一种适用女性补充荷尔蒙的生物药剂及生产方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100441555C (zh) | 2008-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1244317C (zh) | 用于提高透明质酸产率的组合物及其制备方法 | |
CN1301543A (zh) | 皮肤外用剂 | |
CN1651568A (zh) | 一种食用菌液体菌种深层发酵工艺 | |
CN1195843C (zh) | 樟芝的固体培养方法,所得固体培养物及其产品与用途 | |
CN1680240A (zh) | 含白藜芦醇和大豆异黄酮的组合物及其制备方法与应用 | |
CN1212856C (zh) | 一种治疗咽喉炎的药物组合物的制备方法 | |
CN1245198C (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN1148175C (zh) | L-苏糖酸钙预防、抑制和治疗骨质疏松和佝偻病的用途 | |
CN1290517C (zh) | 一种蜂胶水溶性固体分散物的制备方法 | |
CN1518989A (zh) | 海狗油软胶囊及其在制备调节血脂保健品中的应用 | |
CN1733279A (zh) | 一种治疗慢性肾衰的药物复合物 | |
CN1895263A (zh) | 牛磺酸在制备含有葛根素的注射剂中的应用 | |
CN1323689C (zh) | 一种治疗前列腺增生的药物及其制备方法 | |
CN1241577C (zh) | 环糊精衍生物的药物用途及其药物组合物 | |
CN1335161A (zh) | 全鹿骨粉胶囊 | |
CN100341501C (zh) | 含有二氢杨梅素和杨梅素的组合物的保健食品 | |
CN1631895A (zh) | 苦杏仁苷的制备方法和苦杏仁苷在制备促进心脑胰及伤口血液循环的苦杏仁苷制剂中的应用 | |
CN100341520C (zh) | 一种具有抗疲劳和延缓衰老功能的鲨烯复合剂 | |
CN1256081C (zh) | 鸦胆子油乳注射液的制备方法 | |
CN100341416C (zh) | 含有蛇葡萄素的保健食品 | |
CN100345539C (zh) | 含有二氢杨梅素和杨梅素的组合物 | |
CN1730083A (zh) | 元合片及其制备方法 | |
CN1569082A (zh) | 一种具有延缓衰老、免疫调节功能的胶囊及其制备方法 | |
CN1733116A (zh) | 治疗高血压症的药物制剂及其制备方法 | |
CN1132623C (zh) | 一种含姬松茸的中药复方制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: XI'AN TIANXINGJIAN NATURE BIOLOGY PRODUCTS CO., LT Free format text: FORMER OWNER: WANG YUN Effective date: 20091204 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091204 Address after: No. 5 Rongxin Road, hi tech Zone, Shaanxi, Xi'an Patentee after: Xi'an Tianxing Jian natural biological products Co.,Ltd. Address before: No. 5 Xin Rong Road, Xi'an hi tech Industrial Development Zone, Xi'an, Shaanxi Patentee before: Wang Yun |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Xi'an Tianxing Jian natural biological products Co.,Ltd. Assignor: Wang Yun Contract fulfillment period: 2009.12.10 to 2014.12.10 Contract record no.: 2009610000156 Denomination of invention: Composition containing resveratrol and soybean isoflavone and its preparation and use Granted publication date: 20081210 License type: Exclusive license Record date: 20091214 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.12.10 TO 2014.12.10; CHANGE OF CONTRACT Name of requester: XI'AN TIANXINGJIAN NATURAL BIOLOGICAL PRODUCTS CO. Effective date: 20091214 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Composition containing resveratrol and soybean isoflavone and its preparation and use Effective date of registration: 20150122 Granted publication date: 20081210 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: Xi'an Tianxing Jian natural biological products Co.,Ltd. Registration number: 2015990000056 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20151105 Granted publication date: 20081210 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: Xi'an Tianxing Jian natural biological products Co.,Ltd. Registration number: 2015990000056 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Composition containing resveratrol and soybean isoflavone and its preparation and use Effective date of registration: 20151109 Granted publication date: 20081210 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: Xi'an Tianxing Jian natural biological products Co.,Ltd. Registration number: 2015990000971 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20081210 |